[1] Tamori A, Enomoto M, Kobayashi S, et al. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus. J Viral Hepat, 2010, 17: 123-129.
[2] Chen CH, Lee CM, Lu SN, et al. Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants. J Hepatol, 2004, 41: 454-461.
[3] Izzedine H, Hulot JS, Lanuay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies. Kidney Int, 2004, 66: 1153-1158.
[4] Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology, 2009, 49(5 Suppl): S185-195.
[5] Fabbriciani G, de Socio GV, Massarotti M, et al. Adefovir induced hypophosphatemic osteomalacia. Scand [J] Infect Dis. 2011, 43: 990-992.
[6] Carpenter TO. The expanding family of hypophosphatemic syndromes. J Bone Miner Metab, 2012, 30: 1-9.
[7] Gifre L, Peris P, Monegal A, et al.Osteomalacia revisited: a report on 28 cases. Clin Rheumatol, 2011, 30: 639-645.
[8] Wang BF, Wang Y, Wang BY, et al.Osteomalacia and Fanconi′s syndrome caused by long-term low-dose adefovir dipivoxil. [J] Clin Pharm Ther. 2015, 40: 345-348.
[9] Lee YS, Kim BK, Lee HJ, et al. Pathologic femoral neck fracture due to fanconi syndrome induced by adefovir dipivoxil therapy for hepatitis B. Clin Orthop Surg, 2016, 8:232-236.
[10] Poh F, Sing WH, Mohan PC, et al.Insufficiency fractures related to low-dose adefovir dipivoxil treatment for chronic hepatitis B. Med [J] Malaysia. 2015, 70: 38-41.
[11] Lin Y, Pan F, Wang Y, et al.Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.Oncol Lett, 2017, 13:307-314.
[12] Jung YK, Yeon JE, Choi JH, et al.Fanconi’s syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient. Gut Liver, 2010, 4:389-393.
[13] Ahmad M.Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome. J Postgrad Med, 2006, 52: 296-297.
[14] Perazella MA.Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.Kidney Int. 2010, 78: 1060-1063.
[15] Girgis CM, Wong T, Ngu MC, et al.Hypophosphataemic osteomalacia in patients on adefovir dipivoxil.J Clin Gastr-oenterol. 2011, 45:468-473.
[16] Wong T, Girgis CM, Ngu MC, et al.Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B.J Clin Endocrinol Metab, 2010, 95: 479-480.
[17] Kwon SY, Ahn SY, Ko SY, et al.A case of osteomalacia related to adefovir in a patient with chronic hepatitis B. Korean J Gastroenterol, 2010, 6: 117-120.
[18] Luxon BA.Bone disorders in chronic liver diseases. Curr Gastroenterol Rep, 2011, 13: 40-48.
[19] Berry JL, Davies M, Mee AP.Vitamin D metabolism, rickets, and osteomalacia.Semin Musculoskelet Radiol, 2002, 6:173-182.
[20] Hain SF, Fogelman I.Nuclear medicine studies in metabolic bone disease.Semin Musculoskelet Radiol, 2002, 6:323-329. |
